Early research (Phase 1)Active Not RecruitingNCT04432857
What this trial is testing
AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63